Publications

Journal Articles

  1. & Antibody–drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment. Interface Focus 6(6), 20160054
  2. Mevalonate Biosynthesis Intermediates Are Key Regulators of Innate Immunity in Bovine Endometritis. The Journal of Immunology 196(2), 823-831.
  3. et. al. Differential Endometrial Cell Sensitivity to a Cholesterol-Dependent Cytolysin Links Trueperella pyogenes to Uterine Disease in Cattle. Biology of Reproduction 90(3), 54-54.
  4. & Epithelial and Stromal Cells of Bovine Endometrium Have Roles in Innate Immunity and Initiate Inflammatory Responses to Bacterial Lipopeptides In Vitro via Toll-Like Receptors TLR2, TLR1, and TLR6. Endocrinology 155(4), 1453-1465.
  5. & Ovarian steroids do not impact bovine endometrial cytokine/chemokine responses to E. coli or LPS in vitro. Reproduction
  6. et. al. SOCS genes expression during physiological and perturbed implantation in bovine endometrium. Reproduction
  7. et. al. Analysis of STAT1 expression and biological activity reveals interferon-tau-dependent STAT1-regulated SOCS genes in the bovine endometrium. Reproduction, Fertility and Development
  8. et. al. Innate immunity and inflammation of the bovine female reproductive tract in health and disease. Reproduction 148(3), R41-R51.
  9. & Development of Pre-Clinical Models for Evaluating the Therapeutic Potential of Candidate siRNA Targeting STAT6. PLoS ONE 9(2), e90338
  10. & Evaluation of nasal epithelium sampling as a tool in the preclinical development of siRNA-based therapeutics for asthma. Journal of Cellular and Molecular Medicine 17(3), 356-364.
  11. & Immunity and Inflammation in the Uterus. Reproduction in Domestic Animals 47, 402-409.
  12. & Explants of Intact Endometrium to Model Bovine Innate Immunity and Inflammation Ex Vivo. American Journal of Reproductive Immunology 67(6), 526-539.
  13. & Identification of small interfering RNA targeting Signal Transducer and Activator of Transcription 6: characterisation and selection of candidates for pre-clinical development. Journal of RNAi and Gene Silencing 6(2), 401-410.
  14. & RNA interference of STAT6 rapidly attenuates ongoing interleukin-13-mediated events in lung epithelial cells. Immunology 127(2), 256-266.
  15. Vaccine production and development. Microbiologist 7(1), 28-30.
  16. & Administration of Antibody to the Lung Protects Mice against Pneumonic Plague. Infection and Immunity 74(5), 3068-3070.
  17. & Protection against Heterologous Burkholderia pseudomallei Strains by Dendritic Cell Immunization. Infection and Immunity 74(3), 1706-1711.
  18. & Immunological responses after immunisation of mice with microparticles containing antigen and single stranded RNA (polyuridylic acid). Vaccine 24(11), 1736-1743.
  19. & Humoral and Cell-Mediated Adaptive Immune Responses Are Required for Protection against Burkholderia pseudomallei Challenge and Bacterial Clearance Postinfection. Infection and Immunity 73(9), 5945-5951.
  20. & Activation of dendritic cells by microparticles containing Bacillus anthracis protective antigen. Vaccine 23(29), 3857-3863.

Book Chapters

  1. & Therapeutic Development and the Evolution of Precision Medicine. In Nanoscience and Nanotechnology for Human Health. (pp. 359-378).

Other Research Outputs

  1. (2005). Investigation of dendritic cells as a vector for vaccine delivery.